Literature DB >> 28323507

Heroin and Methamphetamine Injection: An Emerging Drug Use Pattern.

Alia Al-Tayyib1, Stephen Koester2, Sig Langegger3, Lisa Raville4.   

Abstract

OBJECTIVE: We sought to describe an emerging drug use pattern characterized by injection of both methamphetamine and heroin. We examined differences in drug injection patterns by demographics, injection behaviors, HIV and HCV status, and overdose.
METHODS: Persons who inject drugs (PWID) were recruited as part of the National HIV Behavioral Surveillance (NHBS) system in Denver, Colorado. We used chi-square statistics to assess differences between those who reported only heroin injection, only methamphetamine injection, and combined heroin and methamphetamine injection. We used generalized linear models to estimate unadjusted and adjusted prevalence ratios to describe the association between drug injection pattern and reported nonfatal overdose in 2015. We also examined changes in the drug reported as most frequently injected across previous NHBS cycles from 2005, 2009, and 2012.
RESULTS: Of 592 participants who completed the survey in 2015, 173 (29.2%) reported only injecting heroin, 123 (20.8%) reported only injecting methamphetamine, and 296 (50.0%) reported injecting both drugs during the past 12 months. Injecting both heroin and methamphetamine was associated with a 2.8 (95% confidence interval: 1.7, 4.5) fold increase in reported overdose in the past 12 months compared with only injecting heroin. The proportion of those reporting methamphetamine as the most frequently injected drug increased from 2.1% in 2005 to 29.6% in 2015 (p < 0.001).
CONCLUSIONS: The rapid increase in methamphetamine injection, and the emergence of combining methamphetamine with heroin, may have serious public health implications.

Entities:  

Keywords:  Heroin; methamphetamine; overdose

Mesh:

Substances:

Year:  2017        PMID: 28323507      PMCID: PMC5642954          DOI: 10.1080/10826084.2016.1271432

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  12 in total

1.  Two genealogies of supported housing and their implications for outcome assessment.

Authors:  Kim Hopper; Susan M Barrow
Journal:  Psychiatr Serv       Date:  2003-01       Impact factor: 3.084

2.  Health behaviors of young adult heroin injectors in the Seattle area.

Authors:  Emily R Cedarbaum; Caleb J Banta-Green
Journal:  Drug Alcohol Depend       Date:  2015-11-17       Impact factor: 4.492

3.  Heroin overdose among young injection drug users in San Francisco.

Authors:  Kristen C Ochoa; Peter J Davidson; Jennifer L Evans; Judith A Hahn; Kimberly Page-Shafer; Andrew R Moss
Journal:  Drug Alcohol Depend       Date:  2005-06-14       Impact factor: 4.492

4.  "Hooked on" prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients.

Authors:  K Michelle Peavy; Caleb J Banta-Green; Susan Kingston; Michael Hanrahan; Joseph O Merrill; Phillip O Coffin
Journal:  J Psychoactive Drugs       Date:  2012 Jul-Aug

5.  Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California: a latent class analysis.

Authors:  Alexis M Roth; Richard A Armenta; Karla D Wagner; Scott C Roesch; Ricky N Bluthenthal; Jazmine Cuevas-Mota; Richard S Garfein
Journal:  Subst Use Misuse       Date:  2014-10-14       Impact factor: 2.164

6.  Factors associated with being asked to initiate someone into injection drug use.

Authors:  Ricky N Bluthenthal; Lynn Wenger; Daniel Chu; Jennifer Lorvick; Brendan Quinn; James P Thing; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2015-02-19       Impact factor: 4.492

7.  Risk factors for nonfatal overdose at Seattle-area syringe exchanges.

Authors:  Lindsay M Jenkins; Caleb J Banta-Green; Charles Maynard; Susan Kingston; Michael Hanrahan; Joseph O Merrill; Phillip O Coffin
Journal:  J Urban Health       Date:  2011-02       Impact factor: 3.671

8.  Polydrug Use and HIV Risk Among People Who Inject Heroin in Tijuana, Mexico: A Latent Class Analysis.

Authors:  Meredith C Meacham; Abby E Rudolph; Steffanie A Strathdee; Melanie L Rusch; Kimberly C Brouwer; Thomas L Patterson; Alicia Vera; Gudelia Rangel; Scott C Roesch
Journal:  Subst Use Misuse       Date:  2015-10-07       Impact factor: 2.164

9.  Characteristics of people who initiate injection drug use later in life.

Authors:  Sonya Arreola; Ricky N Bluthenthal; Lynn Wenger; Daniel Chu; James Thing; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2014-02-26       Impact factor: 4.492

10.  Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.

Authors:  Christopher M Jones; Joseph Logan; R Matthew Gladden; Michele K Bohm
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-10       Impact factor: 17.586

View more
  64 in total

1.  Quantifying enhanced risk from alcohol and other factors in polysubstance-related deaths.

Authors:  Zheng Dai; Marie A Abate; D Leann Long; Gordon S Smith; Theresa M Halki; James C Kraner; Allen R Mock
Journal:  Forensic Sci Int       Date:  2020-05-31       Impact factor: 2.395

2.  Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014 : A Study of Health Care Encounter Data.

Authors:  Mary E Evans; Marissa Person; Brigg Reilley; Jessica Leston; Richard Haverkate; Jeffrey T McCollum; Andria Apostolou; Michele K Bohm; Michelle Van Handel; Danae Bixler; Andrew J Mitsch; Dana L Haberling; Sarah M Hatcher; Thomas Weiser; Kim Elmore; Eyasu H Teshale; Paul J Weidle; Philip J Peters; Kate Buchacz
Journal:  Public Health Rep       Date:  2020-07-07       Impact factor: 2.792

3.  Estimating the Number of People Who Inject Drugs in A Rural County in Appalachia.

Authors:  Sean T Allen; Allison O'Rourke; Rebecca Hamilton White; Kristin E Schneider; Michael Kilkenny; Susan G Sherman
Journal:  Am J Public Health       Date:  2019-01-24       Impact factor: 9.308

4.  Characterising the increasing prevalence of crystal methamphetamine use in Vancouver, Canada, from 2006-2017: A gender-based analysis.

Authors:  Paxton Bach; Kanna Hayashi; M-J Milloy; Ekaterina Nosova; Thomas Kerr; Evan Wood; Nadia Fairbairn
Journal:  Drug Alcohol Rev       Date:  2020-07-14

5.  Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington.

Authors:  Sara Nelson Glick; Richard Burt; Kim Kummer; Joe Tinsley; Caleb J Banta-Green; Matthew R Golden
Journal:  Drug Alcohol Depend       Date:  2017-11-16       Impact factor: 4.492

6.  Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths.

Authors:  Joshua A Barocas; Jianing Wang; Brandon D L Marshall; Marc R LaRochelle; Amy Bettano; Dana Bernson; Curt G Beckwith; Benjamin P Linas; Alexander Y Walley
Journal:  Drug Alcohol Depend       Date:  2019-05-08       Impact factor: 4.492

7.  Increasing substance use disorder counselors' self-efficacy and skills in talking to patients about sex and HIV risk: A randomized training trial.

Authors:  Mary A Hatch-Maillette; Robin Harwick; John S Baer; Elizabeth A Wells; Tatiana Masters; Audra Robinson; Kasie Cloud; Michelle Peavy; Katharina Wiest; Lynette Wright; Kathleen Dillon; Blair Beadnell
Journal:  Drug Alcohol Depend       Date:  2019-04-18       Impact factor: 4.492

8.  Methamphetamine Use and Its Correlates among Individuals with Opioid Use Disorder in a Midwestern U.S. City.

Authors:  Raminta Daniulaityte; Sydney M Silverstein; Timothy N Crawford; Silvia S Martins; William Zule; Angela J Zaragoza; Robert G Carlson
Journal:  Subst Use Misuse       Date:  2020-05-22       Impact factor: 2.164

9.  Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis.

Authors:  Theodore J Cicero; Matthew S Ellis; Zachary A Kasper
Journal:  Am J Public Health       Date:  2019-12-19       Impact factor: 9.308

Review 10.  Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women.

Authors:  Marcela C Smid; Torri D Metz; Adam J Gordon
Journal:  Clin Obstet Gynecol       Date:  2019-03       Impact factor: 2.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.